Analysis of outcomes and prognostic factors of acute lymphoblastic leukemia patients treated by MCP841 protocol: A regional cancer center experience

BACKGROUND: A dramatic improvement in the survival of acute lymphoblastic leukemia (ALL) patients in the last three decades has been observed. MCP 841 protocol is an old but effective tool with tolerable toxicities. The objective of this study was to estimate the relapse-free survival of ALL patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Akhil, Kalwar, Ashok, Kumar, Narender, Singhal, Mukesh Kumar, Beniwal, Surender, Kumar, Harvindra Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121999/
https://www.ncbi.nlm.nih.gov/pubmed/27904561
http://dx.doi.org/10.4103/1735-1995.178754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121999/
https://www.ncbi.nlm.nih.gov/pubmed/27904561
http://dx.doi.org/10.4103/1735-1995.178754

Ejemplares similares